| Artículo | 2024 |
DOLAMA 200: effectiveness and safety of a dual therapy with dolutegravir plus lamivudine in treatment-experienced HIV -1 infected real world participants in Spain
|
Viruses |
| Artículo | 2024 |
HIV-1-DNA/RNA and immunometabolism in monocytes: contribution to the chronic immune activation and inflammation in people with HIV-1
|
EBIOMEDICINE |
| Artículo | 2024 |
Long-term effectiveness, safety, and tolerability of doravirine in antiretroviral-experienced people with HIV in real life
|
MICROBIOLOGY SPECTRUM |
| Artículo | 2024 |
Long-term effects on immunological, inflammatory markers, and HIV-1 reservoir after switching to a two-drug versus maintaining a three-drug regimen based on integrase inhibitors
|
FRONTIERS IN IMMUNOLOGY |
| Short Survey | 2024 |
Plasma concentrations of IL-6, MIP-1β, IP-10, and PTX-3 as predictors of the immunological response to antiretroviral treatment in people with HIV
|
FRONTIERS IN IMMUNOLOGY |
| Artículo | 2024 |
The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers.
|
JOURNAL OF CLINICAL INVESTIGATION |
| Artículo | 2024 |
Vedolizumab and ART in recent HIV-1 infection unveil the role of α4β7 in reservoir size
|
JCI insight |
| Artículo | 2023 |
Decay kinetics of HIV-1-RNA in seminal plasma with dolutegravir/lamivudine versus dolutegravir plus emtricitabine/tenofovir alafenamide in treatment-naive people living with HIV
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2023 |
HIV-1-specific T-cell responses and exhaustion profiles in people with HIV after switching to dual therapy vs. maintaining triple therapy based on integrase inhibitors
|
BIOMEDICINE & PHARMACOTHERAPY |
| Artículo | 2023 |
Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine administered
|
FRONTIERS IN IMMUNOLOGY |
| Artículo | 2023 |
Long-term evolution in liver disease markers and immune and lipid profiles in vertically HIV/HCV-coinfected youths with sustained viral response after direct-acting antivirals therapy
|
BIOMEDICINE & PHARMACOTHERAPY |
| Letter | 2023 |
Response to: Reply to: Anti-CD4 autoantibodies in immunological nonresponder people living with HIV: cause of CD4+ T cell depletion?
|
AIDS |
| Artículo | 2023 |
Toll-like receptor agonists enhance HIV-specific T cell response mediated by plasmacytoid dendritic cells in diverse HIV-1 disease progression phenotypes
|
EBIOMEDICINE |
| Artículo | 2022 |
Ampicillin plus ceftriaxone combined therapy for enterococcus faecalis infective endocarditis in opat
|
JOURNAL OF CLINICAL MEDICINE |
| Artículo | 2022 |
Anti-CD4 autoantibodies in immunological nonresponder people with HIV: cause of CD4 + T-cell depletion?
|
AIDS |
| Artículo | 2022 |
Brief report: evaluation of inflammation and atherogenesis biomarkers through 148 weeks postswitch to dolutegravir and rilpivirine in SWORD-1/SWORD-2
|
Journal of acquired immune deficiency syndromes (1999) |
| Artículo | 2022 |
Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients
|
PLOS ONE |
| Artículo | 2022 |
Immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in elderly people.
|
JCI insight |
| Artículo | 2022 |
Immunological and inflammatory changes after simplifying to dual therapy in virologically suppressed HIV-infected patients through week 96 in a randomized trial
|
CLINICAL MICROBIOLOGY AND INFECTION |
| Artículo | 2022 |
Incidence Rate and Risk Factors for Anal Squamous Cell Carcinoma in a Cohort of People Living With HIV from 2004 to 2017: Implementation of a Screening Program
|
DISEASES OF THE COLON & RECTUM |
| Artículo | 2022 |
Low CD4/CD8 ratio is associated with increased morbidity and mortality in late and non-late presenters: results from a multicentre cohort study, 2004-2018
|
BMC INFECTIOUS DISEASES |
| Artículo | 2022 |
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: a Spanish nationwide cohort
|
HIV MEDICINE |
| Artículo | 2022 |
Similar CD4/CD8 Ratio Recovery After Initiation of Dolutegravir Plus Lamivudine Versus Dolutegravir or Bictegravir-Based Three-Drug Regimens in Naive Adults With HIV
|
FRONTIERS IN IMMUNOLOGY |
| Corrección | 2021 |
Corrigendum: “Ceftriaxone pharmacokinetics by a sensitive and simple LC–MS/MS method: Development and application” (Journal of Pharmaceutical and Biomedical Analysis (2020) 189, (S0731708520313704), (10.1016/j.jpba.2020.113484))
|
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS |
| Artículo | 2021 |
COVID-19 in hospitalized HIV-positive and HIV-negative patients: a matched study
|
HIV MEDICINE |
| Artículo | 2021 |
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection
|
CELLULAR & MOLECULAR IMMUNOLOGY |
| Corrección | 2021 |
Erratum for Herrera-Hidalgo et al., "Is once-daily high-dose ceftriaxone plus ampicillin an alternative for enterococcus faecalis infective endocarditis in outpatient parenteral antibiotic therapy programs?"
|
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Corrección | 2021 |
Erratum: Ampicillin and ceftriaxone solution stability at different temperatures in outpatient parenteral antimicrobial therapy (Antimicrobial Agents and Chemotherapy (2020) 64:7 (e00309-20) DOI: 10.1128/AAC.00309-20)
|
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2021 |
Is once-daily high-dose ceftriaxone plus ampicillin an alternative for enterococcus faecalis infective endocarditis in outpatient parenteral antibiotic therapy programs?
|
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2021 |
Late presentation for HIV remains a major health issue in Spain: results from a multicenter cohort study, 2004–2018
|
PLOS ONE |
| Artículo | 2021 |
Mesenchymal stromal cells in human immunodeficiency virus-infected patients with discordant immune response: early results of a phase I/II clinical trial
|
STEM CELLS TRANSLATIONAL MEDICINE |
| Artículo | 2021 |
SARS-CoV-2 viral load in nasopharyngeal swabs is not an independent predictor of unfavorable outcome
|
Scientific reports |
| Artículo | 2020 |
Ampicillin and Ceftriaxone Solution Stability at Different Temperatures in Outpatient Parenteral Antimicrobial Therapy
|
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2020 |
Brief Report: CYP27B1 rs10877012 T Allele Was Linked to Non-AIDS Progression in ART-Naïve HIV-Infected Patients: A Retrospective Study
|
Journal of acquired immune deficiency syndromes (1999) |
| Artículo | 2020 |
CD300a identifies a CD4+ memory T cell subset with a higher susceptibility to HIV-1 infection
|
AIDS |
| Artículo | 2020 |
Ceftriaxone pharmacokinetics by a sensitive and simple LC–MS/MS method: development and application
|
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS |
| Artículo | 2020 |
Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2020 |
Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study
|
AIDS RESEARCH AND THERAPY |
| Artículo | 2020 |
Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study
|
LANCET HIV |
| Revisión | 2020 |
Enterococcus faecalis endocarditis and outpatient treatment: a systematic review of current alternatives
|
Antibiotics |
| Artículo | 2020 |
How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain
|
HIV MEDICINE |
| Artículo | 2020 |
Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2020 |
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy A Cohort Study
|
Annals of Internal Medicine |
| Artículo | 2020 |
Is immune recovery different depending on the use of integrase strand transfer inhibitor-, non-nucleoside reverse transcriptase- or boosted protease inhibitor-based regimens in antiretroviral-naive HIV-infected patients?
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2020 |
Modulation of monocyte activation and function during direct antiviral agents treatment in HIV coinfected patients
|
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2020 |
Persistent HIV-controllers are more prone to spontaneously clear HCV: a retrospective cohort study
|
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY |
| Artículo | 2020 |
Physicians' opinions on generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection: a multicentre survey in Spain
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2020 |
Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)
|
Scientific reports |
| Artículo | 2019 |
DOLAMA study: Effectiveness, safety and pharmacoeconomic analysis of dual therapy with dolutegravir and lamivudine in virologically suppressed HIV-1 patients
|
MEDICINE |
| Artículo | 2019 |
Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2018)
|
Enfermedades infecciosas y microbiología clínica |
| Artículo | 2019 |
High-resolution anoscopy in HIV-infected men: Assessment of the learning curve and factors that improve the performance
|
PAPILLOMAVIRUS RESEARCH |
| Artículo | 2019 |
High-risk Human Papilloma Virus Testing Improves Diagnostic Performance to Predict Moderate- to High-grade Anal Intraepithelial Neoplasia in Human Immunodeficiency Virus-infected Men Who Have Sex With Men in Low-to-Absent Cytological Abnormalities
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2019 |
Response to a reinforced hepatitis B vaccination scheme in HIV-infected patients under real-life conditions
|
VACCINE |
| Artículo | 2019 |
Response to Hepatitis A Virus Vaccine in HIV-Infected Patients Within a Retrospective, Multicentric Cohort: Facing Hepatitis A Outbreaks in the Clinical Practice
|
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES |
| Artículo | 2019 |
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|
LANCET |
| Artículo | 2018 |
Absolute CD4(+) T cell count overstate immune recovery assessed by CD4(+)/CD8(+) ratio in HIV-infected patients on treatment
|
PLOS ONE |
| Artículo | 2018 |
Darunavir/cobicistat showing similar effectiveness as darunavir/ritonavir monotherapy despite lower trough concentrations
|
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY |
| Artículo | 2018 |
Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients
|
JOURNAL OF INFECTIOUS DISEASES |
| Artículo | 2018 |
Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients
|
MEDICINE |
| Nota | 2018 |
Long-term Persistent Elite HIV-controllers: The Right Model of Functional Cure
|
EBIOMEDICINE |
| Artículo | 2018 |
Low-Level Viremia Is Associated With Clinical Progression in HIV-Infected Patients Receiving Antiretroviral Treatment
|
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES |
| Artículo | 2018 |
No difference in effectiveness of treatment simplification to boosted or unboosted atazanavir plus lamivudine in virologically suppressed in HIV-1-infected patients
|
PLOS ONE |
| Artículo | 2018 |
Switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from dolutegravir plus abacavir and lamivudine in virologically suppressed adults with HIV-1: 48 week results of a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial
|
LANCET HIV |
| Artículo | 2017 |
HIV-1 p24 and CD4(+)T cell count during boosted protease-inhibitor monotherapy in HIV-infected patients
|
Enfermedades infecciosas y microbiología clínica |
| Artículo | 2017 |
Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy
|
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
| Artículo | 2017 |
Pharmacokinetic interactions between cobicistat-boosted elvitegravir and darunavir in HIV-infected patients
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2017 |
Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach
|
PLOS ONE |
| Artículo | 2017 |
Viral Kinetics in Semen With Different Antiretroviral Families in Treatment-Naive Human Immunodeficiency Virus-Infected Patients: A Randomized Trial
|
CLINICAL INFECTIOUS DISEASES |
| Letter | 2016 |
Antiretroviral Therapy in Early HIV Infection
|
NEW ENGLAND JOURNAL OF MEDICINE |
| Letter | 2016 |
Early initiation of antiretroviral therapy: Debate over?
|
LANCET INFECTIOUS DISEASES |
| Artículo | 2016 |
Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens
|
PLOS ONE |
| Artículo | 2016 |
Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models
|
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2016 |
Higher Activation in CD4(+) T Cells But Similar Viral Control Among HIV/Hepatitis C Virus-Coinfected Patients on a Simplification Monotherapy
|
AIDS RESEARCH AND HUMAN RETROVIRUSES |
| Revisión | 2016 |
Impact of HIV on the severity of influenza
|
EXPERT REVIEW OF RESPIRATORY MEDICINE |
| Artículo | 2016 |
Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013
|
JOURNAL OF INFECTION |
| Artículo | 2016 |
MicroRNA profile in CD8+T-Lymphocytes from HIV-infected individuals: relationship with antiviral immune response and disease progression
|
PLOS ONE |
| Artículo | 2016 |
Off-label use of rilpivirine in combination with emtricitabine and tenofovir in HIV-1-infected pediatric patients A multicenter study
|
MEDICINE |
| Artículo | 2016 |
Protease inhibitor monotherapy is effective in controlling human immunodeficiency virus 1 shedding in the male genital tract
|
CLINICAL MICROBIOLOGY AND INFECTION |
| Artículo | 2016 |
Relationship between plasma bilirubin level and oxidative stress markers in HIV-infected patients on atazanavir- vs. efavirenz-based antiretroviral therapy
|
HIV MEDICINE |
| Artículo | 2015 |
Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy
|
PLOS ONE |
| Artículo | 2015 |
Boosted Lopinavir- Versus Boosted Atazanavir-Containing Regimens and Immunologic, Virologic, and Clinical Outcomes: A Prospective Study of HIV-Infected Individuals in High-Income Countries
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2015 |
Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study
|
LANCET HIV |
| Artículo | 2015 |
Differential Effects of Viremia and Microbial Translocation on Immune Activation in HIV-Infected Patients Throughout Ritonavir-Boosted Darunavir Monotherapy
|
MEDICINE |
| Artículo | 2015 |
Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain
|
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
| Artículo | 2015 |
Does Once-Daily Raltegravir Have Any Role in the Antiretroviral Treatment?
|
MEDICINE |
| Artículo | 2015 |
Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia
|
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
| Artículo | 2015 |
Low concordance and resistance mutation emergence in the HIV protease gene among circulating and cell-associated viruses at viral replication episodes during darunavir/ritonavir monotherapy
|
HIV MEDICINE |
| Artículo | 2015 |
Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection
|
PLOS ONE |
| Artículo | 2015 |
Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term
|
HEPATOLOGY |
| Artículo | 2015 |
No Differences of Immune Activation and Microbial Translocation Among HIV-infected Children Receiving Combined Antiretroviral Therapy or Protease Inhibitor Monotherapy
|
MEDICINE |
| Artículo | 2015 |
Shorter Telomere Length Predicts Poorer Immunological Recovery in Virologically Suppressed HIV-1-Infected Patients Treated With Combined Antiretroviral Therapy
|
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES |
| Artículo | 2015 |
Telaprevir and Ribavirin Interaction: Higher Ribavirin Levels Are Not Only Due to Renal Dysfunction during Triple Therapy
|
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2015 |
Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults
|
CLINICAL MICROBIOLOGY AND INFECTION |
| Artículo | 2015 |
Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)
|
CLINICAL MICROBIOLOGY AND INFECTION |
| Artículo | 2014 |
A 24-Week Treatment Strategy With Pegylated Interferon/Ribavirin in HIV/Hepatitis C Virus Genotype 3-Coinfected Patients Who Achieved a Rapid Virologic Response Results in a High Sustained Virologic Response Rate
|
CLINICAL INFECTIOUS DISEASES |
| Letter | 2014 |
Atazanavir-based therapy with pegylated interferon and ribavirin for patients with hepatitis C and HIV
|
LANCET INFECTIOUS DISEASES |
| Artículo | 2014 |
Cellular HIV reservoir replenishment is not affected by blip or intermittent viremia episodes during darunavir/ritonavir monotherapy
|
AIDS |
| Artículo | 2014 |
Clinical and Virological Efficacy of Etravirine Plus Two Active Nucleos(t)ide Analogs in an Heterogeneous HIV-Infected Population
|
PLOS ONE |
| Artículo | 2014 |
Clinically Relevant Transmitted Drug Resistance to First Line Antiretroviral Drugs and Implications for Recommendations
|
PLOS ONE |
| Artículo | 2014 |
Compliance with national guidelines for HIV treatment and its association with mortality and treatment outcome: a study in a Spanish cohort
|
HIV MEDICINE |
| Artículo | 2014 |
Darunavir minimum plasma concentration and ritonavir-boosted darunavir monotherapy outcome in HIV-infected patients
|
ANTIVIRAL THERAPY |
| Artículo | 2014 |
HCV Viral Decline at Week 2 of Peg-IFN-Alpha-2a/RBV Therapy as a Predictive Tool for Tailoring Treatment in HIV/HCV Genotype 1 Co-Infected Patients
|
PLOS ONE |
| Artículo | 2014 |
Immune activation throughout a boosted darunavir monotherapy simplification strategy
|
CLINICAL MICROBIOLOGY AND INFECTION |
| Artículo | 2014 |
Impact of the peginterferon-alpha 2a and ribavirin plasma levels on viral kinetics and sustained virological response in genotype 1 HCV/HIV-co-infected patients with the unfavourable non-CC IL28B genotypes
|
JOURNAL OF VIRAL HEPATITIS |
| Artículo | 2014 |
Incidence of Hepatitis C Virus (HCV) in a Multicenter Cohort of HIV-Positive Patients in Spain 2004-2011: Increasing Rates of HCV Diagnosis but Not of HCV Seroconversions
|
PLOS ONE |
| Artículo | 2014 |
Liver Fibrosis, Host Genetic and Hepatitis C Virus Related Parameters as Predictive Factors of Response to Therapy against Hepatitis C Virus in HIV/HCV Coinfected Patients
|
PLOS ONE |
| Artículo | 2014 |
Microbial translocation and T cell activation are not associated in chronic HIV-infected children
|
AIDS |
| Resumen congreso | 2014 |
Monotherapy with darunavir/ritonavir is effective and safe in clinical practice
|
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY |
| Artículo | 2014 |
Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries
|
AIDS |
| Artículo | 2014 |
Role of Ritonavir in the Drug Interactions Between Telaprevir and Ritonavir-Boosted Atazanavir
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2014 |
Tuberculosis in a cohort of HIV-positive patients: epidemiology, clinical practice and treatment outcomes
|
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE |
| Artículo | 2013 |
All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997-2010
|
BMC INFECTIOUS DISEASES |
| Artículo | 2013 |
Atazanavir-Based Therapy Is Associated with Higher Hepatitis C Viral Load in HIV Type 1-Infected Subjects with Untreated Hepatitis C
|
AIDS RESEARCH AND HUMAN RETROVIRUSES |
| Artículo | 2013 |
Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/Hepatitis C virus-coinfected patients with compensated cirrhosis
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2013 |
Incidence and risk factors of AIDS-defining cancers in a cohort of HIV-positive adults: Importance of the definition of incident cases
|
Enfermedades infecciosas y microbiología clínica |
| Artículo | 2013 |
Inequalities in HIV disease management and progression in migrants from Latin America and sub-Saharan Africa living in Spain
|
HIV MEDICINE |
| Artículo | 2013 |
Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients
|
AIDS |
| Artículo | 2013 |
Lopinavir Plasma Concentrations and Virological Outcome with Lopinavir-Ritonavir Monotherapy in HIV-1-Infected Patients
|
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2013 |
Persistence of novel first-line antiretroviral regimes in a cohort of HIV-positive subjects, CoRIS 2008-2010
|
ANTIVIRAL THERAPY |
| Artículo | 2013 |
Risk of Liver Decompensation Among HIV/Hepatitis C Virus-Coinfected Individuals With Advanced Fibrosis: Implications for the Timing of Therapy
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2013 |
Safety profile of rilpivirine: General and neuropsychiatric tolerability, safety in patients with hepatitis B or C viruses, and lipid profile
|
Enfermedades infecciosas y microbiología clínica |
| Artículo | 2013 |
The IL28B effect on hepatitis C virus kinetics among HIV patients after the first weeks of pegylated-interferon/ribavirin treatment varies according to hepatitis C virus-1 subtype
|
AIDS |
| Artículo | 2012 |
Analysis of transmitted drug resistance in Spain in the years 2007-2010 documents a decline in mutations to the non-nucleoside drug class
|
CLINICAL MICROBIOLOGY AND INFECTION |
| Artículo | 2012 |
Definition of Advanced Age in HIV Infection: Looking for an Age Cut-Off
|
AIDS RESEARCH AND HUMAN RETROVIRUSES |
| Artículo | 2012 |
Differences in HCV Viral Decline between Low and Standard-Dose Pegylated-Interferon-Alpha-2a with Ribavirin in HIV/HCV Genotype 3 Patients
|
PLOS ONE |
| Artículo | 2012 |
Differences in the causes of death of HIV-positive patients in a cohort study by data sources and coding algorithms
|
AIDS |
| Artículo | 2012 |
Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care
|
ANTIVIRAL THERAPY |
| Artículo | 2012 |
HAVCR1 Gene Haplotypes and Infection by Different Viral Hepatitis C Virus Genotypes
|
CLINICAL AND VACCINE IMMUNOLOGY |
| Artículo | 2012 |
Hepatic safety of efavirenz in HIV/hepatitis C virus-coinfected patients with advanced liver fibrosis
|
JOURNAL OF INFECTION |
| Artículo | 2012 |
Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients
|
HEPATOLOGY |
| Artículo | 2012 |
Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients
|
AIDS |
| Artículo | 2012 |
Impact of Antiretroviral Therapy on Tuberculosis Incidence Among HIV-Positive Patients in High-Income Countries
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2012 |
Influence of IL28B Polymorphisms on Response to a Lower-Than-Standard Dose peg-IFN-alpha 2a for Genotype 3 Chronic Hepatitis C in HIV-Coinfected Patients
|
PLOS ONE |
| Artículo | 2012 |
Intracellular and plasma pharmacokinetics of 400 mg of etravirine once daily versus 200 mg of etravirine twice daily in HIV-infected patients
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2012 |
Liver Toxicity of Initial Antiretroviral Drug Regimens Including Two Nucleoside Analogs Plus One Non-Nucleoside Analog or One Ritonavir-Boosted Protease Inhibitor in HIV/HCV-Coinfected Patients
|
HIV CLINICAL TRIALS |
| Artículo | 2012 |
Most HIV Type 1 Non-B Infections in the Spanish Cohort of Antiretroviral Treatment-Naive HIV-Infected Patients (CoRIS) Are Due to Recombinant Viruses
|
JOURNAL OF CLINICAL MICROBIOLOGY |
| Artículo | 2012 |
Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2012 |
Response to Pegylated Interferon Plus Ribavirin Among HIV/Hepatitis C Virus-Coinfected Patients With Compensated Liver Cirrhosis
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2012 |
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study
|
AIDS |
| Artículo | 2011 |
Improved Viral Suppression After Treatment Optimization in HIV-Infected Patients With Persistent Low-Level Viremia
|
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES |
| Artículo | 2011 |
Linkage of the Hepatitis C Virus Genotype and Interleukin-28B Genetic Polymorphisms in Asian Patients Reply
|
HEPATOLOGY |
| Letter | 2011 |
Linkage of the Hepatitis C Virus Genotype and Interleukin-28B Genetic Polymorphisms in Asian Patients Reply
|
HEPATOLOGY |
| Artículo | 2011 |
Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2011 |
Liver toxicity of antiretroviral combinations including Fosamprenavir plus Ritonavir 1400/100mg once daily in HIV/Hepatitis C virus-coinfected patients
|
AIDS Patient Care and ST Ds |
| Artículo | 2011 |
Prevalence and resistance mutations of non-B HIV-1 subtypes among immigrants in Southern Spain along the decade 2000-2010
|
VIROLOGY JOURNAL |
| Artículo | 2011 |
Sensitivity of seven HIV subtyping tools differs among subtypes/recombinants in the Spanish cohort of naive HIV-infected patients (CoRIS)
|
ANTIVIRAL RESEARCH |
| Letter | 2011 |
Simplified Human Immunodeficiency Virus Maintenance Therapy in Virologically Suppressed Children With Ritonavir-boosted Protease Inhibitor Monotherapy
|
PEDIATRIC INFECTIOUS DISEASE JOURNAL |
| Artículo | 2011 |
The cohort of the spanish hiv research network (coris) and its associated biobank; organizational issues, main findings and losses to follow-up
|
Enfermedades infecciosas y microbiología clínica |
| Revisión | 2011 |
The role of insulin resistance in HIV/hepatitis C virus-coinfected patients
|
CURRENT OPINION IN HIV AND AIDS |
| Artículo | 2011 |
When to Initiate Combined Antiretroviral Therapy to Reduce Mortality and AIDS-Defining Illness in HIV-Infected Persons in Developed Countries An Observational Study
|
Annals of Internal Medicine |
| Artículo | 2010 |
Concomitant nevirapine therapy is associated with higher efficacy of pegylated interferon plus ribavirin among HIV/ hepatitis C Virus-Coinfected patients
|
Journal of AIDS and Clinical Research |
| Artículo | 2010 |
Efficacy, safety and pharmacokinetic of once-daily boosted saquinavir (1500/100 mg) together with 2 nucleos(t)ide reverse transcriptase inhibitors in real life: a multicentre prospective study
|
AIDS RESEARCH AND THERAPY |
| Artículo | 2010 |
Increased Regulatory T Cell Counts in HIV-Infected Nonresponders to Hepatitis B Virus Vaccine
|
JOURNAL OF INFECTIOUS DISEASES |
| Artículo | 2010 |
Infección por el virus de la inmunodeficiencia humana en diferentes grupos de edad: implicaciones potenciales para la prevención. Cohorte CoRIS, España, 2004-2008
|
MEDICINA CLINICA |
| Artículo | 2010 |
Nevirapine-based antiretroviral therapy is associated with lower plasma hepatitis C virus viral load among HIV/ hepatitis C Virus-Coinfected patients
|
Journal of AIDS and Clinical Research |
| Artículo | 2010 |
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals
|
AIDS |
| Artículo | 2009 |
Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV-infected, therapy-naive patients: results of the EPIC study (CCR100136)
|
HIV MEDICINE |
| Artículo | 2009 |
Decrease in Serial Prevalence of Coinfection with Hepatitis C Virus among HIV-Infected Patients in Spain, 1997-2006
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2009 |
Delayed Diagnosis of HIV Infection in a Multicenter Cohort: Prevalence, Risk Factors, Response to HAART and Impact on Mortality
|
CURRENT HIV RESEARCH |
| Artículo | 2009 |
Determination and pharmacokinetic profile of liposomal foscarnet in rabbit ocular tissues after intravitreal administration
|
EXPERIMENTAL EYE RESEARCH |
| Artículo | 2009 |
Fast Fibrosis Progression Between Repeated Liver Biopsies in Patients Coinfected with Human Immunodeficiency Virus/Hepatitis C Virus
|
HEPATOLOGY |
| Artículo | 2009 |
HCV RNA in peripheral blood cell subsets in HCV-HIV coinfected patients at the end of PegIFN/RBV treatment is associated with virologic relapse
|
JOURNAL OF VIRAL HEPATITIS |
| Artículo | 2009 |
High seroprevalence but low incidence of HCV infection in a cohort of patients with sexually transmitted HIV in Andalusia, Spain
|
Journal of the International Association of Physicians in AIDS Care |
| Artículo | 2009 |
HIV infection in immigrants in Spain: Epidemiological characteristics and clinical presentation in the CoRIS Cohort (2004-2006)
|
Enfermedades infecciosas y microbiología clínica |
| Artículo | 2009 |
Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2009 |
Risk Factors, CD4 Long-Term Evolution and Mortality of HIV-Infected Patients who Persistently Maintain Low CD4 Counts, Despite Virological Response to HAART
|
CURRENT HIV RESEARCH |
| Artículo | 2009 |
Stepped-Dose Versus Full-Dose Efavirenz for HIV Infection and Neuropsychiatric Adverse Events A Randomized Trial
|
Annals of Internal Medicine |
| Artículo | 2009 |
Virological and immunological stability in HIV infected patients undergoing partial-treatment interruption
|
JOURNAL OF CLINICAL VIROLOGY |
| Artículo | 2008 |
Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients
|
JOURNAL OF HEPATOLOGY |
| Artículo | 2008 |
Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patients
|
AIDS |
| Artículo | 2008 |
Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2008 |
Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2008 |
Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status
|
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE |
| Artículo | 2008 |
Long-term assessment of didanosine, lamivudine, and efavirenz in antiretroviral-naive patients: 3-year follow-up
|
AIDS RESEARCH AND HUMAN RETROVIRUSES |
| Artículo | 2008 |
Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir
|
ANTIVIRAL THERAPY |
| Artículo | 2008 |
Molecular epidemiology of HIV type 1 in newly diagnosed patients in southern Spain
|
AIDS RESEARCH AND HUMAN RETROVIRUSES |
| Artículo | 2008 |
Patients' characteristics and clinical implications of suboptimal CD4 T-cell gains after 1 year of successful antiretroviral therapy
|
CURRENT HIV RESEARCH |
| Artículo | 2008 |
Pharmacology, pharmacokinetic features and interactions of atazanavir
|
Enfermedades infecciosas y microbiología clínica |
| Artículo | 2008 |
Role of Pegylated Interferon-alpha-2a and Ribavirin Concentrations in Sustained Viral Response in HCV/HIV-Coinfected Patients
|
CLINICAL PHARMACOLOGY & THERAPEUTICS |
| Artículo | 2008 |
Very Low Prevalence and No Clinical Significance of Occult Hepatitis B in a Cohort of HIV-Infected Patients with Isolated Anti-HBc Seropositivity: The BHOI Study
|
HIV CLINICAL TRIALS |
| Artículo | 2007 |
Efficacy of Low-Dose Boosted Saquinavir Once Daily Plus Nucleoside Reverse Transcriptase Inhibitors in Pregnant HIV-1-Infected Women With a Therapeutic Drug Monitoring Strategy
|
Therapeutic Drug Monitoring |
| Artículo | 2007 |
Clinical and pharmacokinetic data support once-daily low-dose boosted saquinavir (1,200 milligrams saquinavir with 100 milligrams ritonavir) in treatment-naive or limited protease inhibitor-experienced human immunodeficiency virus-infected patients
|
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2007 |
Efficacy of low-dose boosted saquinavir once daily plus nucleoside reverse transcriptase inhibitors in pregnant HIV-1-infected women with a therapeutic drug monitoring strategy
|
Therapeutic Drug Monitoring |
| Artículo | 2007 |
Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2007 |
Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients
|
ANTIVIRAL THERAPY |
| Artículo | 2007 |
Randomized clinical trial investigating three chemoprophylaxis regimens for latent tuberculosis infection in HIV-infected patients
|
Enfermedades infecciosas y microbiología clínica |
| Artículo | 2007 |
Rapid virological response at week 4 predicts response to pegylated interferon plus ribavirin among HIV/HCV-coinfected patients
|
ANTIVIRAL THERAPY |
| Artículo | 2007 |
The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 2006 |
Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C
|
ANTIVIRAL THERAPY |
| Artículo | 2006 |
Clinical Outcome of HIV-Infected Patients with Sustained Virologic Response to Antiretroviral Therapy: Long-Term Follow-Up of a Multicenter Cohort
|
PLOS ONE |
| Artículo | 2006 |
Efavirenz trough levels are not associated with virological failure throughout therapy with 800 mg daily and a rifampicin-containing antituberculosis regimen
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Artículo | 2006 |
Efavirenz trough levels are not associated with virological failure throughout therapy with 800 mg daily and a rifampicin-containing antituberculosis regimen
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
| Letter | 2006 |
Efectos adversos neuropsiquiátricos asociados con efavirenz
|
Enfermedades infecciosas y microbiología clínica |
| Revisión | 2006 |
Interactions that can compromise response to antiretroviral therapy
|
Enfermedades infecciosas y microbiología clínica |
| Artículo | 2006 |
Pharmacological and pharmacokinetic characteristics and interactions
|
Enfermedades Infecciosas y Microbiologia Clinica Monografias |
| Artículo | 2005 |
Discontinuation of antiretroviral therapy in patients with chronic HIV infection: Clinical, virologic, and immunologic consequences
|
AIDS Patient Care and ST Ds |
| Artículo | 2005 |
Influence of treatment and immunological recovery on tuberculosis relapses in HIV-infected patients
|
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE |
| Artículo | 2005 |
Influence of treatment and immunological recovery on tuberculosis relapses in HIV-infected patients
|
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE |
| Artículo | 2005 |
MONITORIZACION TERAPEUTICA Y COCIENTE INHIBITORIO DE LOS FARMACOS ANTIRRETROVIRALES. ¿SON APLICABLES A NUESTRA REALIDAD?.
|
Enfermedades infecciosas y microbiología clínica |
| Artículo | 2005 |
Simplicity and efficacy of a once-daily antiretroviral regimen with didanosine, lamivudine, and efavirenz in naive patients: The VESD study
|
HIV CLINICAL TRIALS |
| Artículo | 2005 |
Therapeutic drug monitoring and the inhibitory quotient of antiretroviral drugs: Can they applied to the current situation?
|
Enfermedades infecciosas y microbiología clínica |
| Artículo | 2005 |
Therapeutic drug monitoring of efavirenz: Trough levels cannot be estimated on the basis of earlier plasma determinations
|
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES |
| Editorial | 2004 |
Supresión del tratamiento antirretroviral ¿es ya una estrategia más?
|
FARMACIA HOSPITALARIA |
| Artículo | 2003 |
Ensayo clínico aleatorizado de tres pautas de quimioprofilaxis para prevenir la tuberculosis en pacientes infectados por el VIH con anergia cutánea
|
Enfermedades infecciosas y microbiología clínica |
| Letter | 2003 |
Once-daily saquinavir-hgc plus low-dose ritonavir (1200/100 mg) in HIV-infected pregnant women: Pharmacokinetics and efficacy
|
HIV CLINICAL TRIALS |
| Letter | 2003 |
Once-daily saquinavir-hgc plus low-dose ritonavir (1200/100 mg) in HIV-infected pregnant women: Pharmacokinetics and efficacy
|
HIV CLINICAL TRIALS |
| Letter | 2003 |
Once-daily saquinavir-sgc plus low-dose ritonavir (1200/100 mg) in combination with efavirenz: Pharmacokinetics and efficacy in HIV-infected patients with prior antiretroviral therapy
|
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES |
| Artículo | 2003 |
Q fever: epidemiology, clinical features and prognosis. A study from 1983 to 1999 in the South of Spain
|
JOURNAL OF INFECTION |
| Capítulo | 2003 |
Trastornos oculares asociados a la infección VIH..
|
La infección por el VIH: guía práctica |
| Artículo | 2002 |
Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis
|
CLINICAL PHARMACOKINETICS |
| Artículo | 2001 |
Acquired immunodeficiency syndrome-related cryptosporidial cholangitis: resolution with endobiliary prosthesis insertion
|
GASTROINTESTINAL ENDOSCOPY |
| Letter | 2001 |
Cidofovir added to highly active antiretroviral therapy in AIDS-associated progressive multifocal leukoencephalopathy
|
AIDS |
| Artículo | 2001 |
Determination of efavirenz in human plasma by high-performance liquid chromatography with ultraviolet detection
|
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences |
| Letter | 2001 |
Efavirenz plasma concentrations and efficiency
|
AIDS |
| Artículo | 2001 |
Influence of the response to induction therapy on the rate of progression of cytomegalovirus retinitis in AIDS patients on intravitreal maintenance therapy
|
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
| Artículo | 2001 |
Intravitreal pharmacokinetics and retinal concentrations of ganciclovir and foscarnet after intravitreal administration in rabbits
|
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE |
| Artículo | 2001 |
RESISTENCIAS A LOS INHIBIDORES DE LA TRANSCRIPTASA INVERSA NO NUCLEÓSIDOS.
|
Enfermedades infecciosas y microbiología clínica |
| Artículo | 2000 |
Cerebrospinal fluid tumor necrosis factor-alpha, interleukin-beta, interleukin-6, and inteuleukin-8 as diagnostic markers of cerebrospinal fluid infection in neurosurgical patients
|
CRITICAL CARE MEDICINE |
| Artículo | 2000 |
Intravitreal, retinal, and central nervous system foscarnet concentrations after rapid intravenous administration to rabbits
|
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Letter | 1999 |
Absence of changes in viral load of the human immunodeficiency virus 1 following delayed cutaneous hypersensitivity test
|
MEDICINA CLINICA |
| Letter | 1999 |
AUSENCIA DE CAMBIOS EN LA VIREMIA PLASMÁTICA DEL VIRUS DE LA INMUNODEFICIÉNCIA HUMANA DESPUÉS DE LA APLICACIÓN DEL TEST DE HIPERSENSIBILIDAD CUTÁNEA RETARDADA
|
MEDICINA CLINICA |
| Artículo | 1999 |
Ausencia de cambios en la viremia plasmática del virus de la inmunodeficiencia humana después de la aplicación del test de hipersensibilidad cutánea retardada
|
MEDICINA CLINICA |
| Artículo | 1999 |
Etiology, clinical features and outcome of splenic microabscesses in HIV-infected patients with prolonged fever
|
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
| Artículo | 1999 |
Meningitis por Cryptococcus neoformans en pacientes con infeccion por el VIH.
|
NEUROLOGIA |
| Artículo | 1999 |
Murine typhus as a common cause of fever of intermediate duration - A 17-year study in the south of Spain
|
Archives of Internal Medicine |
| Revisión | 1998 |
Avances en el diagnostico y tratamiento de las infecciones causadas por Herpesvirus y virus JC
|
Enfermedades infecciosas y microbiología clínica |
| Artículo | 1998 |
Comparison of two methods for the assessment of delayed-type hypersensitivity skin responses in patients with human immunodeficiency virus infection
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 1998 |
Digital necrosis due to Leishmania species infection in a patient with AIDS
|
CLINICAL INFECTIOUS DISEASES |
| Letter | 1998 |
Retroperitoneal fibrosis in a patient with human immunodeficiency virus infection
|
Archives of Internal Medicine |
| Letter | 1997 |
Ergotism related to concurrent administration of ergotamine tartrate and ritonavir in an AIDS patient
|
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 1997 |
Estudio del Foscarnet como alternativa al tratamiento antiherpético
|
Ciencia pharmacéutica |
| Letter | 1997 |
Foscarnet and AIDS-associated Kaposi's sarcoma
|
AIDS |
| Artículo | 1997 |
Interleukin 6 in cerebrospinal fluid of patients with meningitis is not a useful diagnostic marker in the differential diagnosis of meningitis
|
ANNALS OF CLINICAL BIOCHEMISTRY |
| Artículo | 1996 |
Determination of shelf life and activation energy for tumor necrosis factor-α in cerebrospinal fluid samples
|
CLINICAL CHEMISTRY |
| Editorial | 1996 |
SITUACION ACTUAL DEL TRATAMIENTO DE LA RETINITIS POR CITOMEGALOVIRUS EN PACIENTES CON SIDA
|
Enfermedades infecciosas y microbiología clínica |
| Artículo | 1995 |
ADENOSINE-DEAMINASE ACTIVITY IN THE CSF OF PATIENTS WITH ASEPTIC-MENINGITIS - UTILITY IN THE DIAGNOSIS OF TUBERCULOUS MENINGITIS OR NEUROBRUCELLOSIS
|
CLINICAL INFECTIOUS DISEASES |
| Artículo | 1995 |
INTERLEUKIN-1-BETA IN PLEURAL FLUIDS OF DIFFERENT ETIOLOGIES - ITS ROLE AS INFLAMMATORY MEDIATOR IN EMPYEMA
|
CHEST |
| Artículo | 1995 |
INTERLEUKIN-8 IN CEREBROSPINAL-FLUID FROM PATIENTS WITH MENINGITIS OF DIFFERENT ETIOLOGIES - ITS POSSIBLE ROLE AS NEUTROPHIL CHEMOTACTIC FACTOR
|
JOURNAL OF INFECTIOUS DISEASES |
| Artículo | 1995 |
MUJER CON ODINOFAGIA, DISFAGIA, TRISMO Y EMPIEMA BILATERAL
|
Enfermedades infecciosas y microbiología clínica |
| Artículo | 1994 |
Antibodies to antigen A60 in cerebrospinal fluid from patients with tuberculous meningitis
|
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
| Letter | 1994 |
TUBERCULOSIS OF THE SKULL - AN UNUSUAL MANIFESTATION
|
Tubercle and Lung Disease |
| Artículo | 1993 |
MEASUREMENT OF LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1-BETA IN THE CSF OF PATIENTS WITH MENINGITIS OF DIFFERENT ETIOLOGIES - UTILITY IN THE DIFFERENTIAL-DIAGNOSIS
|
CLINICAL INFECTIOUS DISEASES |
| Letter | 1992 |
Agranulocytosis caused by ticlopidine
|
NEUROLOGIA |
| Letter | 1992 |
Induced agranulocytosis by ticlopidine
|
NEUROLOGIA |
| Artículo | 1992 |
Pneumothorax secondary to septic pulmonary emboli in tricuspid endocarditis
|
THORAX |
| Letter | 1991 |
Arthropathy associated with human immunodeficiency virus
|
REVISTA CLINICA ESPANOLA |
| Letter | 1991 |
Artritis séptica por Streptococcus agalactiae en paciente con cirrosis hepática.
|
Enfermedades infecciosas y microbiología clínica |
| Letter | 1991 |
Multicavitating pneumonia caused by Pneumocystis carinii
|
MEDICINA CLINICA |
| Letter | 1991 |
TUBERCULOUS SPLENIC ABSCESSES IN PATIENTS WITH THE ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME
|
TUBERCLE |
| Letter | 1990 |
Lyme disease in the province of Sevilla
|
MEDICINA CLINICA |
| Letter | 1990 |
Malignant form of mediterranean spotted fever: Importance of early therapy
|
Enfermedades infecciosas y microbiología clínica |
| Letter | 1990 |
Muscle enzymes in human trichinosis
|
Enfermedades infecciosas y microbiología clínica |
| Letter | 1989 |
Tick-Borne Relapsing Fever in Intravenous Drug Abusers
|
JOURNAL OF INFECTIOUS DISEASES |
| Letter | 1988 |
Pericarditis caused by Coxiella burnetti
|
MEDICINA CLINICA |
| Artículo | 1984 |
Computed tomographic brain scan findings in Q fever encephalitis
|
NEURORADIOLOGY |
| Letter | 1984 |
Familial urticaria induced by cold
|
MEDICINA CLINICA |
| Artículo | 1984 |
Usefulness of the indirect immunofluorescence test and the rose bengal test in the diagnosis of brucellosis
|
REVISTA CLINICA ESPANOLA |
| Artículo | 1983 |
Hypokaliemic myopathy and metabolic alkalosis following topic therapy with 9-alpha-fluoroprednisolone
|
REVISTA CLINICA ESPANOLA |
| Artículo | 1983 |
Leptospirosis en nuestro medio. Estudio de 17 casos.
|
REVISTA CLINICA ESPANOLA |
| Artículo | 1983 |
Murine typhus: clinical and serological review of 42 cases
|
MEDICINA CLINICA |
| Artículo | 1982 |
Rickettsiosis. Presentacion de 13 casos.
|
REVISTA CLINICA ESPANOLA |
